SAN DIEGO, June 10, 2021 /PRNewswire/ -- Cardiff Oncology, Inc. , a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical needs for new... | June 10, 2021
/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical...